| Date | Time | Source | Headline | Symbol | Company |
| 09/28/2007 | 9:00AM | PR Newswire (US) | Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs | NASDAQ:IDIX | (MM) |
| 09/06/2007 | 4:05PM | PR Newswire (US) | Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences | NASDAQ:IDIX | (MM) |
| 08/02/2007 | 4:05PM | PR Newswire (US) | Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results | NASDAQ:IDIX | (MM) |
| 07/13/2007 | 6:45AM | PR Newswire (US) | Valopicitabine Development Program Placed on Clinical Hold in the United States | NASDAQ:IDIX | (MM) |
| 06/18/2007 | 10:06AM | PR Newswire (US) | Idenix Pharmaceuticals, Inc. Names Ronald C. Renaud Jr. as Chief Financial Officer | NASDAQ:IDIX | (MM) |
| 06/12/2007 | 8:00AM | PR Newswire (US) | Valopicitabine Combined with Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment i | NASDAQ:IDIX | (MM) |
| 05/29/2007 | 9:30AM | PR Newswire (US) | Idenix Pharmaceuticals To Present at the Bear Stearns Biotech Confab and the Goldman Sachs 28th Annual Global Healthcare Confere | NASDAQ:IDIX | (MM) |
| 05/15/2007 | 9:30AM | PR Newswire (US) | Idenix Pharmaceuticals to Present at Citi's 2007 Healthcare Conference | NASDAQ:IDIX | (MM) |
| 04/30/2007 | 3:00AM | PR Newswire (US) | Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients | NASDAQ:IDIX | (MM) |
| 04/26/2007 | 5:05PM | PR Newswire (US) | Idenix Pharmaceuticals Reports First Quarter Financial Results | NASDAQ:IDIX | (MM) |
| 04/23/2007 | 5:05PM | PR Newswire (US) | Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences | NASDAQ:IDIX | (MM) |
| 04/18/2007 | 5:05PM | PR Newswire (US) | Idenix Announces Data Presentations at the 2007 Digestive Disease Week Meeting | NASDAQ:IDIX | (MM) |
| 04/17/2007 | 5:38PM | PR Newswire (US) | Idenix to Host Conference Call Discussing First Quarter 2007 Financial Results | NASDAQ:IDIX | (MM) |
| 04/12/2007 | 8:55AM | PR Newswire (US) | Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C G | NASDAQ:IDIX | (MM) |
| 03/20/2007 | 5:05PM | PR Newswire (US) | Idenix Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer | NASDAQ:IDIX | (MM) |
| 03/06/2007 | 4:05PM | PR Newswire (US) | Idenix Pharmaceuticals to Present at the Cowen & Company 27th Annual Healthcare Conference | NASDAQ:IDIX | (MM) |
| 03/02/2007 | 7:30AM | PR Newswire (US) | Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results | NASDAQ:IDIX | (MM) |
| 03/02/2007 | 7:00AM | PR Newswire (US) | SEBIVO(R) (Telbivudine) Approved in China as New Treatment Option for Patients with Chronic Hepatitis B | NASDAQ:IDIX | (MM) |
| 03/01/2007 | 4:05PM | PR Newswire (US) | Preclinical Data From Two Novel Idenix Compounds for the Treatment of HIV Presented at Conference on Retroviruses and Opportunis | NASDAQ:IDIX | (MM) |
| 03/01/2007 | 11:00AM | PR Newswire (US) | Idenix Announces Thirteen Data Presentations at the 2007 European Association For the Study of the Liver | NASDAQ:IDIX | (MM) |
| 02/23/2007 | 7:45AM | PR Newswire (US) | SEBIVO(R) (telbivudine) Recommended for Approval in European Union as a new Treatment for Patients with Chronic Hepatitis B | NASDAQ:IDIX | (MM) |
| 02/20/2007 | 8:30AM | PR Newswire (US) | Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference | NASDAQ:IDIX | (MM) |
| 02/16/2007 | 8:30AM | PR Newswire (US) | Idenix to Host Conference Call Discussing Fourth Quarter and Year-End 2006 Financial Results | NASDAQ:IDIX | (MM) |
| 02/16/2007 | 8:30AM | PR Newswire (US) | Idenix to Host Conference Call Discussing Fourth Quarter and Year-End 2006 Financial Results | NASDAQ:IDIX | (MM) |
| 01/31/2007 | 8:30AM | PR Newswire (US) | Idenix Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference | NASDAQ:IDIX | (MM) |
| 01/31/2007 | 8:30AM | PR Newswire (US) | Idenix Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference | NASDAQ:IDIX | (MM) |
| 01/08/2007 | 5:00PM | PR Newswire (US) | Idenix Pharmaceuticals, Inc. Announces Appointment of Douglas Mayers, M.D. as Executive Vice President and Chief Medical Officer | NASDAQ:IDIX | (MM) |
| 01/03/2007 | 8:45AM | PR Newswire (US) | Idenix Pharmaceuticals To Present at the JP Morgan 25th Annual Healthcare Conference | NASDAQ:IDIX | (MM) |
| 12/07/2006 | 8:30AM | PR Newswire (US) | Norman C. Payson, M.D., Elected to Board of Directors of Idenix Pharmaceuticals | NASDAQ:IDIX | (MM) |
| 12/07/2006 | 8:30AM | PR Newswire (US) | Norman C. Payson, M.D., Elected to Board of Directors of Idenix Pharmaceuticals | NASDAQ:IDIX | (MM) |